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OBJECTIVE: Silent brain infarctions are the silent cerebrovascular events that are distinguished from
symptomatic lacunar infarctions by their ‘silence’; the origin of these infarctions is still unclear. This study
analyzed the characteristics of silent and symptomatic lacunar infarctions and sought to explore the mechanism
of this ‘silence’.
METHODS: In total, 156 patients with only silent brain infarctions, 90 with only symptomatic lacunar
infarctions, 160 with both silent and symptomatic lacunar infarctions, and 115 without any infarctions were
recruited. Vascular risk factors, leukoaraiosis, and vascular assessment results were compared. The National
Institutes of Health Stroke Scale scores were compared between patients with only symptomatic lacunar
infarctions and patients with two types of infarctions. The locations of all of the infarctions were evaluated. The
evolution of the two types of infarctions was retrospectively studied by comparing the infarcts on the magnetic
resonance images of 63 patients obtained at different times.
RESULTS: The main risk factors for silent brain infarctions were hypertension, age, and advanced leukoaraiosis;
the main factors for symptomatic lacunar infarctions were hypertension, atrial fibrillation, and atherosclerosis
of relevant arteries. The neurological deficits of patients with only symptomatic lacunar infarctions were more
severe than those of patients with both types of infarctions. More silent brain infarctions were located in the
corona radiata and basal ganglia; these locations were different from those of the symptomatic lacunar
infarctions. The initial sizes of the symptomatic lacunar infarctions were larger than the silent brain infarctions,
whereas the final sizes were almost equal between the two groups.
CONCLUSIONS: Chronic ischemic preconditioning and nonstrategic locations may be the main reasons for the
‘silence’ of silent brain infarctions.
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Silent brain infarctions (SBIs) are very common in the
elderly (1). SBIs are believed to be caused by the occlusion of
small vessels and are therefore categorized as a small vessel
disease (SVD); SVDs are related to different types of
arteriole degeneration (2,3). SBIs are mainly identified by
imaging tools (4) and are difficult to distinguish from old
symptomatic lacunar infarctions (SLIs), which are also
caused by the occlusion of small vessels and are usually
regarded as SVDs (2). Except for the different signals on
diffusion-weighted images (DWIs) during the acute phase
of SLIs, the lack of stroke-like symptoms or ‘silence’ is the
only prominent feature used to distinguish SBIs from SLIs
(1,4).
However, the ‘silence’ of SBIs is still confusing to
researchers and clinicians. The relatively small sizes of SBIs
are the only widely accepted explanation for this peculiar
feature (1,5). However, SLIs that result in obvious symptoms
can also be small. Several recent studies on the evolution of
SLIs indicate that their final sizes are much smaller than those
measured for DWIs after the onset of stroke (6-8). Thus, the
difference between the sizes of SBIs and SLIs may require
further evaluation. The size-related explanation for the
‘silence’ of SBIs is also worth investigating.
Previous studies on lacunar infarcts mostly investigated
the difference between SLI patients with or without SBIs
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(5,9,10); few studies focused on the ‘silence’ of SBIs.
Furthermore, no study has compared the evolution of SBIs
and SLIs. In this study, four groups were designed
according to the presence of SBIs and SLIs. Vertical and
horizontal comparisons of the following characteristics were
performed among groups: risk factors, locations, evolution
of infarctions, leukoaraiosis, atherosclerosis (AS) of relevant
vessels, and the NIH Stroke Scale (NIHSS) scores of patients
with SLIs. Based on the comparisons, we determined the
possible mechanisms responsible for the ‘silence’ of SBIs.
& MATERIALS AND METHODS
General population of patients
This study was based on patients diagnosed with acute
lacunar infarction or patients confirmed to have no signs of
stroke who consecutively visited the Department of
Neurology of the 10th People’s Hospital in Shanghai from
December 2011 to August 2012. The patients had neurologic
deficits, nonspecific symptoms (such as headaches), and
dizziness; alternatively, they had a fear of stroke because of
the presence of risk factors. The patients were administered
a medical evaluation protocol, including brain magnetic
resonance imaging (MRI), electrocardiogram, and blood
tests for blood glucose, lipids, and homocysteine. All
patients also underwent a vascular assessment involving
either computed tomography angiography (CTA) or mag-
netic resonance angiography (MRA). Patients diagnosed
with acute lacunar infarction were evaluated using the
NIHSS. All procedures were approved by the Institutional
Review Board of our hospital, and written informed consent
was obtained from every participant.
Based on the presence of SBIs and SLIs on MRIs, 521
patients were enrolled and divided into four groups,
namely, SBI, SLI, SBI&SLI (SS), and control groups. These
groups consisted of the following patients: 156 patients with
only SBIs, 90 patients with only new SLIs, 160 patients with
both SBIs and new SLIs, and 115 patients without any
identified infarcts. The following patients were excluded
from these four groups: patients diagnosed with other types
of stroke but not acute lacunar infarction, patients with a
history of stroke, and patients with metallic implants.
In addition to the MRI results of the four groups listed
above, two sets of images were analyzed retrospectively to
study the evolution of SBIs and SLIs: 1) previous MR images
of the 32 patients in the SBI and SS groups who underwent
MRI more than once and 2) previous MR images obtained
after the onset of stroke for the other 31 patients with
lacunes identified as old SLIs.
MRI protocol
The MR images in this study were primarily obtained
using a 1.5 T scanner (Philips, Eindhoven, Noord-Brabant,
Netherlands) and a 3.0 T scanner (Siemens, Erlangen,
Bavaria, Germany). The MRI protocol consisted of a T1-
weighted image [repetition time/echo time (TR/TE) = 101/
1.92 for the 1.5 T scanner and 2000/9 for the 3.0 T scanner],
fluid attenuated inversion recovery images (FLAIR) (TR/
TE = 6000/110 for the 1.5 T scanner and 8500/94 for the 3.0 T
scanner), DWI (TR/TE = 3393/86 for the 1.5 T scanner and
6000/94 for the 3.0 T scanner) in the axial plane, and a T2-
weighted image (TR/TE = 1940/120 for the 1.5 T scanner
and 4540/96 for the 3.0 T scanner) in the sagittal plane with
16 layers.
Review and criteria of the MR images
All MR images were analyzed by two radiologists blinded
to the clinical data. The discrepancies between the inter-
pretations of the two readers regarding the presence of SBIs
and SLIs and the leukoaraiosis scores were resolved by a
visual consensus.
According to the conclusion on the evolution of acute
lacunar infarctions, we defined SLI as a ,25-mm-diameter
focal lesion that is hyper-intense on a DWI among small
penetrating arteries distributed in the thalamus, gang-
liocapsular regions, corona radiata, and brainstem (7). An
SBI was defined as a .3-mm-diameter focal cavitated lesion
that is hypo-intense on T1-weighted images, hyper-intense
on T2-weighted images, hypo-intense with a hyper-intense
boundary on FLAIR images, and without corresponding
stroke-like symptoms or neurologic deficits (4). An old SLI
was defined as a focal lesion with signals similar to an SBI
on T1- and T2-weighted images, with signals similar to
cavitations or leukoaraiosis on FLAIR, and with a corre-
sponding history of stroke-like symptoms or neurologic
deficits (7,8,11). Old SLIs were analyzed only when the
corresponding MR images after the onset of stroke were
accessible at our workstation. The diameters of acute SLIs
were measured on DWIs, T1-weighted images, and FLAIR
images. The diameters of SBIs and old SLIs were measured
on T1-weighted images and FLAIR images. All diameters
listed for statistical analysis were the average of values
measured by the two readers.
Leukoaraiosis was scored from 0 to 3 according to
Fazekas’ scale (12). Grades 2 to 3 leukoaraiosis were
regarded as advanced leukoaraiosis (ad-LA).
Vascular risk factors and vascular assessment
Data related to the following factors were collected:
hypertension, diabetes mellitus (DM), dyslipidemia,
ischemic heart disease (IHD), atrial fibrillation (AF),
hyperhomocysteinemia (HHCY), smoking, and CTA or
MRA results. Atherosclerotic plaques and stenosis of
infarction-related arteries (e.g., middle cerebral and internal
carotid arteries for infarctions in the gangliocapsular regions
and basilar and vertebral arteries for infarctions in the
brainstem) were considered to be possible atherosclerotic
sources. AF diagnosed before or during hospitalization was
regarded as a possible cardiogenic mechanism.
Statistical analyses
All data were analyzed using SPSS (version 18.0, SPSS,
Inc., Chicago, IL, USA). ANOVA and chi-squared tests were
performed to compare the baseline characteristics and
locations. The Student’s t-test was used to compare
infarction sizes and NIHSS scores. Multiple logistic regres-
sion models were constructed to determine the risk factors
for SBIs and SLIs. p,0.05 was considered to indicate a
significant difference.
& RESULTS
Baseline characteristics of the four groups
Table 1 lists the baseline characteristics of age, prevalence
of different vascular risk factors, AS of relevant arteries, ad-
LA, and the proportions of patients who underwent MRI on
the 1.5 T scanner and CTA as the method of vascular
assessment. Compared with the control group, the patients
in the other three groups were relatively older and had
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higher prevalence rates of hypertension, HHCY, IHD, and
ad-LA. The prevalence rates of DM, dyslipidemia, AF, and
AS were also higher in the SLI group than in the control
group.
Multiple comparisons among the SBI, SLI, and SS groups
were also performed, and positive significant results
(p,0.05) are shown in Table 2. Compared with the SLI
group, patients in the SBI and SS groups were relatively
older with higher prevalence rates of HHCY and ad-LA and
lower prevalence rates of dyslipidemia and AS. No
difference was observed for the prevalence of hypertension
among the three groups. However, the durations of
hypertension for hypertensive patients in the SBI and SS
groups were significantly longer than for those in the SLI
group (both p,0.01). The NIHSS scores were higher in the
SLI group than in the SS group (p= 0.017).
Risk factors of SBIs and SLIs vs. the control group
Multiple regression models were constructed to identify
the risk factors for different infarcts. The control group
served as a reference, and the SS group was excluded. Sex,
age, hypertension prevalence, DM, dyslipidemia, HHCY,
IHD, AF, smoking, AS of relevant arteries, and ad-LA were
added to the two models. The results are listed in Table 3.
Locations of SBIs and SLIs
The locations of the SBIs and SLIs in the SBI, SLI, and SS
groups were subsequently investigated, and the results are
listed in Table 4. Compared with SLIs, more SBIs were
located in the corona radiata (p,0.01) and fewer were
located in the internal capsule and brainstem (p,0.01 for
both locations).
Size and evolution of infarcts
The diameters of the SBIs and SLIs were compared among
groups and different time points. The average diameters of
the SBIs and SLIs were determined based on all infarcts in
the SBI, SLI, and SS groups. The comparisons among
different time points were performed based on the MR
images of 63 patients, i.e., 32 patients with 67 SBIs and 31
patients with 31 old SLIs obtained at different times. The
results indicated that the sizes of the SBIs changed slightly
after an average period of 13.4 months, whereas the SLIs
shrank considerably after 13.0 months to final sizes nearly
equal to those of the SBIs (p= 0.24). The details of this
analysis are shown in Table 5.
& DISCUSSION
This study revealed that the risk factors for the SBI and
SLI groups differed to some extent and that the risk factors
of the SS group were similar to those of the SBI group. The
main risk factors for SBIs were hypertension, age, and
HHCY; the main risk factors for SLIs were hypertension,
DM, dyslipidemia, IHD, and AF. Patients with SBIs had
long-term hypertension with a high prevalence of ad-LA,
whereas the prevalence of AS in relevant arteries was much
higher in the SLI and SS groups. Based on these different
risk factors and features, the specific mechanisms of arterial
occlusion can be speculated to differ between SBIs and SLIs.
The classic mechanisms of SVDs, such as arteriolosclerosis
caused by long-term hypertension, may be the main
pathogenesis of SBIs. However, AS and embolisms are
more important for SLIs (5,10,13,14). The specific hyperten-
sion and leukoaraiosis-related pathogenesis of SBIs differs
from the pathogenesis of SLIs and may be the main reason
for the ‘silence’ of SBIs.
Leukoaraiosis represents incomplete ischemia caused by
the stenosis of small vessels. This condition progresses with
age, and long-term hypertension that causes chronic
arteriolosclerosis and arteriolar stenosis further aggravates
the ischemia (15,16). Furthermore, SBIs are commonly found
to coexist with leukoaraiosis (17). Thus, incomplete and
chronic ischemia may also be the basis for SBIs. Prior to the
appearance of SBIs, the particular region supplied by the
arteriole with chronic arteriolosclerosis may be irreversibly
and covertly impaired because of ischemia and may
gradually lose its function. SBIs form after the threshold of
ischemic stress is broken by the progress of ischemia. Thus,
the ‘silence’ of SBIs can be explained by chronic ischemic
Table 1 - Baseline characteristics of the different groups.
SBI (n=156) SLI (n=90) SS (n=160) Control (n=115)
Female (%) 50.6 51.1 48.1 55.7
Age (years) 68.9¡7.0b 63.7¡7.3b 70.7¡7.0b 58.2¡8.2
Hypertension (%) 88.5b 80.0b 86.9b 31.3
Diabetes (%) 19.2 30.0 b 21.3a 11.3
Dyslipidemia (%) 64.1 78.9 b 61.3 54.8
Hyperhomocysteinemia (%) 69.2 b 45.6 a 65.6 b 30.4
Ischemic heart disease (%) 14.1 a 16.7 a 13.8 a 5.2
Atrial fibrillation (%) 7.7 12.2 a 8.1 3.5
Current smoking (%) 25.0 30.0 a 35.0 b 15.7
Advanced leukoaraiosis (%) 53.8 b 25.5 b 60.1 b 7.8
Atherosclerosis (%) 14.7 47.8 b 30.6 b 5.2
CTA (%) 73.7 77.8 69.4 79.1
1.5 T (%) 72.4 74.4 76.3 73.9
ap,0.05, b p,0.01 vs. the control group.
Table 2 - Positive results of the multiple comparisons.







Dyslipidemia Atherosclerosisb Hyperhomocysteinemia b
Hyperhomocysteinemia b Advanced leukoaraiosisb
Advanced leukoaraiosisb Atherosclerosisb
Atherosclerosisb NIH Stroke Scale scores
bp,0.01.
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preconditioning and long-term ischemic tolerance. The
comparison of the results between the SLI and SS groups
in this study supports this explanation. The SS group
consisted of significantly older patients than the SLI group,
with longer hypertension durations but lower NIHSS scores.
The lower NIHSS scores can be attributed to the neuropro-
tective effect of SBIs similar to the effects of previous
transient ischemic attacks (TIA) (18-20). For both TIA and
SBIs, ischemic preconditioning and ischemic tolerance may
be the most reasonable explanations for this effect (21-23).
Another possible mechanism for the ‘silence’ based on
chronic ischemia is that the cavity of an SBI may gradually
form within several days or even months with the
progression of ischemia similar to the chronic progression
of leukoaraiosis (15) (i.e., no stroke-onset and neurologic
symptoms). In fact, some SBIs are difficult to distinguish
from focal leukoaraiosis. In our study on the evolution of
infarctions, we observed that several SBIs tended to enlarge
over time. However, this trend was not obvious and cannot
be supported without frequent follow-up MRIs.
However, this study revealed that AS of relevant arteries
was a strong risk factor for SLIs. In fact, Fisher and Caplan’s
pathological studies in the last century demonstrated that
AS in perforating and parent arteries was an important
cause for SLIs (14,24). Some recent imaging studies also
verified the association between SLIs and AS in parent and
other relevant arteries (25-27). In addition, AS in parent
arteries without obvious lumen stenosis and in perforating
arteries could not be detected by most imaging tools;
therefore, it might be underestimated as a common cause
for SLIs (27). Our results verified the association between
SLIs and AS. However, IHD and AF were also identified as
risk factors for single SLIs in this study. It has been
suggested that single SLIs could also be caused by a cardiac
embolism (10,28). Therefore, the pathogenesis of some SLIs,
particularly those without coexisting SBIs, might be differ-
ent from the chronic and incomplete ischemic pattern of
SBIs and instead may be similar to the pattern of large
infarctions caused by acute and complete arterial occlusion
due to AS or embolism. The benefit of thrombolytic therapy
(29) for SLI patients could also support this conclusion. In
addition, most patients in the SLI group did not have
leukoaraiosis or long-term hypertension. With a different
pattern of arterial occlusion due to a different pathogenesis
and without the pathological basis of chronic ischemia and
neuroprotection of ischemic tolerance, these SLIs resulted in
acute symptoms.
However, it is difficult to explain the overt symptoms of
those SLIs without identified AS or with coexisting SBIs and
leukoaraiosis. It is still possible that some of the SLIs might
be related to acute and complete occlusion caused by
undetectable AS of perforating arteries (27). However, this
hypothesis cannot be proven without pathological evidence.
Meanwhile, it is not reasonable to attribute all of those SLIs
to AS. The different locations can also be a possible reason
for the ‘silence’ and ‘overtness’ of the infarcts. This study
showed that more SBIs were identified in the corona radiata
and basal ganglia; these locations were different from the
distribution of SLIs. Compared with the internal capsule
and brain stem, where more important conducting bundles
and nuclei are concentrated, the corona radiata and basal
ganglia are relatively nonstrategic areas, where small
infarctions may cause only mild or even no symptoms.
This study also confirmed that the average final size of the
SLIs was nearly equal to that of the SBIs. Therefore, the
amount of brain tissue destroyed by the SLIs may be equal
to the amount for the SBIs; consequently, the size-related
explanation for the ‘silence’ of SBIs might not be reasonable.
The overestimation of the infarction size using DWIs may be
caused by acute inflammation and edema, which exacerbate
neurologic symptoms (30,31). These pathological changes
were also reported to be related to acute and complete
Table 3 - Risk factors for SBI and SLI vs. the control group.
SBI vs. control SLI vs. control
OR (95% CI) p-value OR (95% CI) p-value
Sex 0.723 (0.280-1.871) 0.504 1.019 (0.369-2.813) 0.970
Age (years) 1.129 (1.024-1.245) 0.015 1.072 (0.977-1.177) 0.142
Hypertension 21.708 (7.668-61.455) 0.000 6.320 (2.679-14.906) 0.000
Diabetes 0.959 (0.238-3.862) 0.953 3.654 (1.227-10.883) 0.020
Dyslipidemia 1.869 (0.736-4.743) 0.188 3.535 (1.422-8.792) 0.007
Hyperhomocysteinemia 8.331 (3.138-22.118) 0.000 1.699 (0.686-4.205) 0.252
Ischemic heart disease 2.139 (0.448-10.222) 0.341 4.163 (1.105-15.691) 0.035
Atrial fibrillation 2.509 (0.334-18.858) 0.372 7.262 (1.094-48.218) 0.040
Smoking 4.605 (1.154-18.380) 0.031 4.095 (1.258-13.328) 0.019
Advanced leukoaraiosis 4.357 (1.978-9.598) 0.000 1.179 (0.522-2.664) 0.692
Atherosclerosis 0.473 (0.101-2.220) 0.343 13.951 (4.628-42.057) 0.000
Table 4 - Locations of the SBIs and SLIs.
SBI (n=702) SLI (n=250)
Basal ganglia 176 (25.07%) 48 (19.2%)
Thalamus 93 (13.25%) 25 (10.00%)
Internal capsule 51 (7.26%) 60 (24.00%)b
Corona radiata 308 (43.87%) 53 (21.20%)b
Brainstem 74 (10.54%) 64 (25.60%)b
ap,0.05, b p,0.01.
Table 5 - Size and evolution of the infarcts.
SBI SLI
Average diameter on T1/FLAIR (mm) 7.9¡2.8 13.9¡4.3b
Average diameter on a DWI (mm) – 14.2¡5.0
Previous diameter on T1/FLAIR (mm)c 8.0¡2.3 14.0¡3.9b
Previous diameter on a DWI (mm)c – 14.3¡4.5
Duration of two time points of MRI
(months)c
13.4¡3.5 13.0¡3.3
Follow-up diameter on T1/FLAIR (mm)c 8.1¡2.3 8.7¡2.7
ap,0.05, b p,0.01, c based on 63 patients with MR images at two time
points.
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ischemia (31) and were not obvious in the pathogenesis of
SBIs observed in the current study. Therefore, this differ-
ence between the evolution of SBIs and SLIs can also be
attributed to the different patterns of ischemia and occlusion
emphasized above.
In conclusion, this study showed that the ‘silence’ of SBIs
can be attributed to chronic ischemic preconditioning and
long-term ischemic tolerance but not to the infarction size.
The nonstrategic locations of these infarcts can also partly
account for the ‘silence’. The strengths of this study
included the consecutive study design with a relatively
large sample size, multiple groups, and comparisons of
different patterns. However, this study also had limitations.
First, the study was not based on the general population,
and the results may be influenced by the limited representa-
tiveness of the sample selected from hospitalized patients.
Second, the study was based on clinical data and neuroima-
ging, and the results of the pathogenesis of SBIs and SLIs
were speculated without confirmation by pathological
examination. We cannot expound further on the pathogen-
esis, and more comprehensive studies are required.
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